These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37797298)

  • 21. Clinical features and outcomes of Myasthenia Gravis associated with COVID-19 vaccines: A systematic review and pooled analysis.
    Tayebi AH; Samimisedeh P; Jafari Afshar E; Ayati A; Ghalehnovi E; Foroutani L; Abbasi Khoshsirat N; Rastad H
    Medicine (Baltimore); 2023 Oct; 102(40):e34890. PubMed ID: 37800781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Immunogenicity of Additional SARS-CoV-2 Vaccinations in a Patient With Myasthenia Gravis on Mycophenolate: A Case Report.
    McNeish BL; Colletti RB; Hehir MK
    J Clin Neuromuscul Dis; 2022 Dec; 24(2):113-114. PubMed ID: 36409346
    [No Abstract]   [Full Text] [Related]  

  • 23. The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review.
    Peng S; Tian Y; Meng L; Fang R; Chang W; Yang Y; Li S; Shen Q; Ni J; Zhu W
    Front Immunol; 2022; 13():1103020. PubMed ID: 36618419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electronic health record derived-impact of COVID-19 on myasthenia gravis.
    Roy B; Kovvuru S; Nalleballe K; Onteddu SR; Nowak RJ
    J Neurol Sci; 2021 Apr; 423():117362. PubMed ID: 33639420
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID19 vaccine in myasthenia gravis patients: safety and possible predictors of disease exacerbation.
    Trinchillo A; Esposito M; Habetswallner F; Tuccillo F; De Martino BM
    Neurol Sci; 2023 Feb; 44(2):447-450. PubMed ID: 36567408
    [No Abstract]   [Full Text] [Related]  

  • 26. Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience.
    Farina A; Falso S; Cornacchini S; Spagni G; Monte G; Mariottini A; Massacesi L; Barilaro A; Evoli A; Damato V
    Eur J Neurol; 2022 Aug; 29(8):2505-2510. PubMed ID: 35390184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study.
    Li HY; Shao LY; Song M; Hu SM; Yue YX; Li HF
    Front Immunol; 2022; 13():923017. PubMed ID: 35990671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis.
    Lotan I; Hellmann MA; Friedman Y; Stiebel-Kalish H; Steiner I; Wilf-Yarkoni A
    Neuromuscul Disord; 2022 Mar; 32(3):230-235. PubMed ID: 35227552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis.
    Holm-Yildiz S; Dysgaard T; Krag T; Pedersen BS; Hamm SR; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Bundgaard H; Garred P; Iversen K; Nielsen SD; Vissing J
    J Neuroimmunol; 2023 Nov; 384():578215. PubMed ID: 37797472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Clinical Course of New-Onset Ocular Myasthenia Gravis Caused by Pfizer-BioNTech COVID-19 Vaccine.
    Su WY; Lu CJ
    Acta Neurol Taiwan; 2023 Dec; 32(4)():218-222. PubMed ID: 37723915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cogan's sign in a patient with suspected post-COVID-19 vaccine-associated myasthenia gravis.
    Tavares-Júnior JWL; Sobreira-Neto MA; Braga-Neto P
    Rev Soc Bras Med Trop; 2023; 56():e0007. PubMed ID: 37283341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia gravis following human papillomavirus vaccination: a case report.
    Chung JY; Lee SJ; Shin BS; Kang HG
    BMC Neurol; 2018 Dec; 18(1):222. PubMed ID: 30593270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves.
    Doron A; Piura Y; Vigiser I; Kolb H; Regev K; Nesher N; Karni A
    J Neurol; 2022 Dec; 269(12):6193-6201. PubMed ID: 35907046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.
    Peric S; Rankovic M; Bozovic I; Radosavljevic V; Marjanovic I; Basta I; Lavrnic D
    Acta Neurol Belg; 2023 Apr; 123(2):529-536. PubMed ID: 36279094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).
    Tackenberg B; Schneider M; Blaes F; Eienbröker C; Schade-Brittinger C; Wellek A; Deschauer M; Eickmann M; Klenk HD; Müller HH; Sommer N
    EBioMedicine; 2018 Feb; 28():143-150. PubMed ID: 29337134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of COVID-19 Vaccine Associated New Diagnosis Myasthenia Gravis.
    Chavez A; Pougnier C
    J Prim Care Community Health; 2021; 12():21501327211051933. PubMed ID: 34709075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Galassi G; Rispoli V; Iori E; Ariatti A; Marchioni A
    Isr Med Assoc J; 2022 Jan; 24(1):9-10. PubMed ID: 35077038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis.
    He D; Zhang H; Xiao J; Zhang X; Xie M; Pan D; Wang M; Luo X; Bu B; Zhang M; Wang W
    Ann Neurol; 2018 Sep; 84(3):386-400. PubMed ID: 30246904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management].
    Worm M; Ring J; Klimek L; Jakob T; Lange L; Treudler R; Beyer K; Werfel T; Biedermann T; Bircher A; Fischer M; Fuchs T; Heller AR; Hoffmann F; Huttegger I; Kopp MV; Kugler C; Lommatzsch M; Pfaar O; Rietschel E; Rueff F; Schnadt S; Seifert R; Stöcker B; Vogelberg C; Sitter H; Gieler U; Brockow K
    MMW Fortschr Med; 2021 Jan; 163(1):48-51. PubMed ID: 33464512
    [No Abstract]   [Full Text] [Related]  

  • 40. Myocarditis Temporally Associated With COVID-19 Vaccination.
    Rosner CM; Genovese L; Tehrani BN; Atkins M; Bakhshi H; Chaudhri S; Damluji AA; de Lemos JA; Desai SS; Emaminia A; Flanagan MC; Khera A; Maghsoudi A; Mekonnen G; Muthukumar A; Saeed IM; Sherwood MW; Sinha SS; O'Connor CM; deFilippi CR
    Circulation; 2021 Aug; 144(6):502-505. PubMed ID: 34133885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.